It is the University’s expectation that only those who are well and not presenting with COVID-19 symptoms attend a Monash campus or location. View our latest updates.
You are here:
Our group specialises in the design, synthesis and biological evaluation of ligands targeting proteins implicated in mental health disorders and cancer.
Our group uses computer-based methods to develop novel anti-infective agents and anti-viral drugs.
Our research improve drug-discovery outcomes by enhancing our capacity to modify molecular structure in response to key-performance criteria.
Our research interest focusses on the design, synthesis and evaluation of small molecules targeting G protein-coupled receptors.
Our group develops cutting-edge molecular imaging tools that allow us to visualise the biological world inside us.
Our group employs a range of biophysical approaches, molecular modelling and design in studies of peptides and proteins from venomous organisms.
We discover new modes of chemical reactivity to develop chemical reactions for the synthesis and manufacture of pharmaceutically relevant molecules.
Our research focusses on the design, synthesis and development of small molecules for a range of protein targets.
Our group specialises in fragment-based drug design and its application to the development of novel antimicrobial agents.
Our group has a general focus on structure-based design and synthesis of enzyme inhibitors and epigenetic modulators.
